Seguir
Ewa Forma
Ewa Forma
Department of Cytobiochemistry, Faculty of Biology and Environmental Protection, University of Lodz
Dirección de correo verificada de biol.uni.lodz.pl
Título
Citado por
Citado por
Año
Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers
A Krzeslak, K Wojcik-Krowiranda, E Forma, P Jozwiak, H Romanowicz, ...
Pathology & Oncology Research 18, 721-728, 2012
2982012
O-GlcNAcylation and Metabolic Reprograming in Cancer
P Jóźwiak, E Forma, M Bryś, A Krześlak
Frontiers in endocrinology 5, 145, 2014
1432014
Gene expression of O-GlcNAc cycling enzymes in human breast cancers
A Krześlak, E Forma, M Bernaciak, H Romanowicz, M Bryś
Clinical and experimental medicine 12, 61-65, 2012
1212012
Anticancer activity of propolis and its compounds
E Forma, M Bryś
Nutrients 13 (8), 2594, 2021
1002021
Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer—the relationship with regulatory hypoxia-inducible factor-1α …
K Starska, E Forma, P Jóźwiak, M Bryś, I Lewy-Trenda, ...
Tumor Biology 36, 2309-2321, 2015
822015
Concentration of cadmium, nickel and aluminium in female breast cancer
H Romanowicz-Makowska, E Forma, M Bryś, WM Krajewska, B Smolarz
Polish Journal of Pathology 62 (4), 257-261, 2011
792011
Prediction of bladder cancer based on urinary content of MGEA5 and OGT mRNA level
W Rozanski, A Krzeslak, E Forma, M Brys, M Blewniewski, P Wozniak, ...
Clinical laboratory 58 (5), 579, 2012
742012
Metallothionein 2A genetic polymorphisms and risk of ductal breast cancer
A Krześlak, E Forma, P Jóźwiak, A Szymczyk, B Smolarz, ...
Clinical and experimental medicine 14, 107-113, 2014
472014
Expression of genes encoding for enzymes associated with O-GlcNAcylation in endometrial carcinomas: clinicopathologic correlations
A Krześlak, E Forma, M Bryś, K Wójcik-Krowiranda, A Bieńkiewicz
Ginekologia polska 83 (1), 2012
422012
Effect of metallothionein 2A gene polymorphism on allele-specific gene expression and metal content in prostate cancer
A Krześlak, E Forma, G Chwatko, P Jóźwiak, A Szymczyk, J Wilkosz, ...
Toxicology and applied pharmacology 268 (3), 278-285, 2013
412013
The potential role of O-GlcNAc modification in cancer epigenetics
E Forma, P Jóźwiak, M Bryś, A Krześlak
Cellular and Molecular Biology Letters 19 (3), 438-460, 2014
402014
Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer
K Starska, E Forma, I Lewy-Trenda, O Stasikowska-Kanicka, M Skóra, ...
Cellular Oncology 41, 253-268, 2018
392018
Differential expression of ten-eleven translocation genes in endometrial cancers
P Ciesielski, P Jóźwiak, K Wójcik-Krowiranda, E Forma, Ł Cwonda, ...
Tumor Biology 39 (3), 1010428317695017, 2017
382017
The expression of SOCS1 and TLR4-NFkappaB pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinoma.
K Starska, E Forma, I Lewy-Trenda, O Stasikowska, M Bryś, ...
Folia Histochemica et Cytobiologica 47 (3), 401-410, 2009
342009
Expression of hypoxia inducible factor 1α and 2α and its association with vitamin C level in thyroid lesions
P Jóźwiak, P Ciesielski, A Zaczek, A Lipińska, L Pomorski, M Wieczorek, ...
Journal of Biomedical Science 24, 1-10, 2017
322017
Gene and protein expression of O-GlcNAc-cycling enzymes in human laryngeal cancer
K Starska, E Forma, E Brzezińska-Błaszczyk, I Lewy-Trenda, M Bryś, ...
Clinical and experimental medicine 15, 455-468, 2015
322015
Metallothionein 2A genetic polymorphisms and risk of prostate cancer in a Polish population
E Forma, A Krzeslak, J Wilkosz, P Jozwiak, A Szymczyk, W Rozanski, ...
Cancer Genetics 205 (9), 432-435, 2012
322012
Polymorphisms of Homologous Recombination RAD51, RAD51B, XRCC2, and XRCC3 Genes and the Risk of Prostate Cancer
M Nowacka-Zawisza, E Wiśnik, A Wasilewski, M Skowrońska, E Forma, ...
Analytical Cellular Pathology 2015 (1), 828646, 2015
312015
Relationship of urinary isoprostanes to prostate cancer occurence
M Brys, A Morel, E Forma, A Krzeslak, J Wilkosz, W Rozanski, B Olas
Molecular and cellular biochemistry 372, 149-153, 2013
312013
Impact of OGT deregulation on EZH2 target genes FOXA1 and FOXC1 expression in breast cancer cells
E Forma, P Jóźwiak, P Ciesielski, A Zaczek, K Starska, M Bryś, A Krześlak
PLoS One 13 (6), e0198351, 2018
302018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20